{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:38:46Z","timestamp":1791419926032,"version":"4.3.3"},"reference-count":62,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim was to discuss the role of non\u2010type 2 inflammation in patients diagnosed with chronic rhinosinusitis (CRS) and comorbid lower airway disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>Medline, Embase, National Institute for Health and Care Excellence, TRIP Database, ProQuest, Clinicaltrials.gov, Cochrane Central Registry of Controlled Trials, Web of Science, government and health organizations, and graduate\u2010level theses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Review Methods<\/jats:title>\n                    <jats:p>This scoping review followed PRISMA\u2010ScR guidelines. Search strategy was peer\u2010reviewed by medical librarians. Studies were included if they utilized airway sampling, non\u2010type 2 cytokines, and patients with CRS and lower airway disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty\u2010seven from 7060 articles were included. In patients with CRS and comorbid asthma, aspirin\u2010exacerbated respiratory disease (AERD), and chronic obstructive pulmonary disease (COPD)\/bronchiectasis, 60% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912), 33% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092), and 100% (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), respectively, demonstrated mixed or non\u2010type 2 endotypes. Comorbid CRS and asthma produced type 1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091.5), type 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), type 3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), mixed type 1\/2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), and mixed type 1\/2\/3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098.5) endotype shifts. AERD demonstrated type 2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20094), mixed type 2\/3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091), and mixed type 1\/2\/3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) endotype shifts. CRS with COPD or bronchiectasis demonstrated a mixed 1\/2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091) endotype shift.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Type 2 disease has been extensively reviewed due to advent biologics targeting type 2 inflammation, but outcomes may be suboptimal due to the presence of non\u2010type 2 inflammation. A proportion of patients with CRS and comorbid lower airway disease demonstrated mixed and non\u2010type 2 endotype shifts. This emphasizes that patients with unified airway disease may have forms of inflammation beyond classical type 2 disease which could inform biologic development.\n                      <jats:italic>Laryngoscope<\/jats:italic>\n                      , 134:1005\u20131013, 2024\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/lary.30992","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T07:04:56Z","timestamp":1692860696000},"page":"1005-1013","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non\u2010Type 2 and Mixed Inflammation in Chronic Rhinosinusitis and Lower Airway Disease"],"prefix":"10.1002","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5086-9220","authenticated-orcid":false,"given":"Austin","family":"Heffernan","sequence":"first","affiliation":[{"name":"Division of Otolaryngology \u2013 Head and Neck Surgery, Department of Surgery University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shafiee","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology \u2013 Head and Neck Surgery, Department of Surgery University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teffran","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology \u2013 Head and Neck Surgery, Department of Surgery University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Sparanese","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology \u2013 Head and Neck Surgery, Department of Surgery University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thamboo","sequence":"additional","affiliation":[{"name":"Division of Otolaryngology \u2013 Head and Neck Surgery, Department of Surgery University of British Columbia  Vancouver Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.013"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13875"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2020.1453"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin17.049"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22652"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2020.12.6.980"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13586"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2020.102587"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000503"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.05.009"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2019.11.5.664"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8712-1"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2019.100094"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.05.004"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13496"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127228"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-012-0495-8"},{"key":"e_1_2_7_19_1","first-page":"205","article-title":"Analysis of the expression of Th\u20101, Th\u20102, Th\u201017 cytokines in patients with allergic and non\u2010allergic bronchial asthma associated with chronic rhinosinusitis with nasal polyps","volume":"74","author":"Dyneva M","year":"2019","journal-title":"Allergy"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.14508"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A1342"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13969"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.05.008"},{"key":"e_1_2_7_24_1","unstructured":"Oxford Centre for Evidence\u2010Based Medicine: Levels of Evidence. Centre for Evidence\u2010Based Medicine. Published March 2009.https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01464.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2017.07.012"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin17.240"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.12.018"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2014.28.4033"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127228"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02065"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.07.008"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005432"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2002.01315.x"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000232566"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1324"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040646"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02028-3"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2278OC"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05474-w"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.007"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.001"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05704-1"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S124248"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.01.013"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40463-022-00580-y"},{"key":"e_1_2_7_47_1","unstructured":"ChriscadenK OsseiranN.WHO Releases Country Estimates on Air Pollution Exposure and Health Impact. World Health Organization.https:\/\/www.who.int\/news\/item\/27-09-2016-who-releases-country-estimates-on-air-pollution-exposure-and-health-impact."},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28764-0"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.03.008"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.03.021"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202108-1943OC"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/clt2.12091"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728214.2020.1819982"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22249"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.02.016"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21038"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706314"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000731"},{"key":"e_1_2_7_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1729736"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"e_1_2_7_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1783242"},{"key":"e_1_2_7_62_1","unstructured":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis (WAYPOINT).ClinicalTrials.gov.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04851964."},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.063"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lary.30992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T07:36:39Z","timestamp":1708068999000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lary.30992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1002\/lary.30992"],"URL":"https:\/\/doi.org\/10.1002\/lary.30992","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"2023-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}